| İnsomninin epidemiyolojisi, patogenezi ve nonfarmakolojik tedavisi üzerine bir güncelleme | Mustafa KAHRİMAN | 87–97 |
| Steps in multiple sclerosis pathogenesis-II: The role of biological markers, sodium channels and glutamate in neurodegeneration | Ömer Faruk AYDIN, Aslı KURNE, Rana KARABUDAK | 98–105 |
| Transcranial magnetic stimulation in idiopathic Parkinson disease | Hülya TİRELİ, Gülbin YÜKSEL, Geysu KARLIKKAYA | 106–111 |
| Asymmetrical lobar degenerations: Clinical, neuropsychological, scanning data | Özen ÇATAN, Neşe TUNCER, Tülin TANRIDAĞ, Önder US, Aynur MOLLAHASANOĞLU, İpek MİDİ | 112–120 |
| Restless leg syndrome and its relationship with Parkinson disease | Derya KAYNAK, Gülçin BENBİR | 121–128 |
| The neuroimmunologic approach to tension type headache and migraine | Hale Zeynep BATUR, Ceyla İRKEÇ, Özlem AKSOY, Hacer DOĞANAY | 129–133 |
| Rehabilitation in multiple sclerosis | Karantay Fatma MUTLUAY | 134–143 |
| The importance of cerebrospinal fluid cytology in leptomeningeal carcinomatosis presenting with intracranial hypertension | Deniz YERDELEN, Semih GİRAY, Başak KARAKURUM, Zülfikar ARLİER, Sibel KARACA, Göksel MELİHA, Tan Mehmet KARATAŞ | 144–148 |
| Pseudotemporal epilepsy with periventricular nodular heterotopia | Aysun ÜNAL, Serap SAYGI | 149–153 |